Yale ASH Updates on the Randomized Controlled Phase 3 ALIFE2 Study: Low-Molecular-Weight Heparin for Women With Recurrent Miscarriage and Inherited Thrombophilia

38 views
March 15, 2023
0 Comments
Login to view comments. Click here to Login